Index -
P/E -
EPS (ttm) -1.09
Insider Own 8.12%
Shs Outstand 70.89M
Perf Week 5.30%
Market Cap 99.05M
Forward P/E -
EPS next Y -0.62
Insider Trans 269.72%
Shs Float 65.48M
Perf Month 24.66%
Income -77.26M
PEG -
EPS next Q -0.20
Inst Own 76.84%
Short Float 3.30%
Perf Quarter 16.81%
Sales 31.12M
P/S 3.18
EPS this Y 37.33%
Inst Trans 0.40%
Short Ratio 2.40
Perf Half Y 11.20%
Book/sh 1.99
P/B 0.70
EPS next Y 21.79%
ROA -38.27%
Short Interest 2.16M
Perf Year -85.92%
Cash/sh 1.80
P/C 0.77
EPS next 5Y -
ROE -48.47%
52W Range 0.59 - 10.15
Perf YTD 32.38%
Dividend Est. -
P/FCF -
EPS past 5Y 20.67%
ROI -53.29%
52W High -86.31%
Beta 0.26
Dividend TTM -
Quick Ratio 6.74
Sales past 5Y 74.29%
Gross Margin 67.36%
52W Low 135.51%
ATR (14) 0.07
Dividend Ex-Date -
Current Ratio 6.74
EPS Y/Y TTM 24.52%
Oper. Margin -287.76%
RSI (14) 64.65
Volatility 5.02% 6.05%
Employees 91
Debt/Eq 0.02
Sales Y/Y TTM 0.95%
Profit Margin -248.28%
Recom 2.78
Target Price 1.84
Option/Short Yes / Yes
LT Debt/Eq 0.02
EPS Q/Q 43.39%
Payout -
Rel Volume 0.45
Prev Close 1.35
Sales Surprise 24.33%
EPS Surprise 16.00%
Sales Q/Q -5.14%
Earnings May 07 AMC
Avg Volume 898.16K
Price 1.39
SMA20 9.75%
SMA50 17.63%
SMA200 -16.09%
Trades
Volume 402,352
Change 2.96%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-22-24 Downgrade
H.C. Wainwright
Buy → Neutral
Nov-13-23 Downgrade
William Blair
Outperform → Mkt Perform
Oct-03-23 Initiated
Evercore ISI
Outperform
$22
Dec-14-22 Initiated
Stifel
Buy
$29
Dec-01-22 Initiated
Goldman
Buy
$25
Oct-06-22 Initiated
BTIG Research
Buy
$32
Jul-23-21 Resumed
Jefferies
Buy
$27 → $32
Jun-15-21 Initiated
Piper Sandler
Overweight
$30
Apr-21-21 Initiated
H.C. Wainwright
Buy
$40
Oct-22-19 Upgrade
SVB Leerink
Mkt Perform → Outperform
Sep-06-19 Downgrade
JMP Securities
Mkt Outperform → Mkt Perform
Jun-27-19 Downgrade
SVB Leerink
Outperform → Mkt Perform
May-06-19 Initiated
SVB Leerink
Outperform
$13
Mar-28-18 Resumed
Leerink Partners
Outperform
$52
Feb-09-18 Initiated
Guggenheim
Buy
$53
Jun-16-17 Initiated
Cantor Fitzgerald
Overweight
$50
Nov-29-16 Initiated
Leerink Partners
Outperform
$54
Sep-30-16 Initiated
JMP Securities
Mkt Outperform
Jun-10-16 Initiated
Guggenheim
Buy
$35
Nov-02-15 Initiated
Jefferies
Buy
$20
Show Previous Ratings
Jul-25-24 09:40AM
Jul-16-24 04:01PM
Jul-02-24 01:27PM
Jun-06-24 07:00AM
May-08-24 12:06PM
07:43AM
Loading…
07:43AM
(Thomson Reuters StreetEvents)
04:06AM
May-07-24 10:56PM
05:15PM
04:11PM
(Associated Press Finance)
04:01PM
Apr-30-24 07:00AM
Apr-23-24 08:00AM
Apr-05-24 09:40AM
Mar-20-24 09:40AM
08:45AM
Loading…
Mar-14-24 08:45AM
Mar-04-24 12:00PM
09:40AM
Feb-27-24 09:35AM
08:38AM
(Associated Press Finance)
07:00AM
Feb-15-24 10:00AM
Feb-13-24 09:40AM
Jan-17-24 11:14AM
Jan-16-24 07:00AM
Jan-10-24 07:00AM
Jan-04-24 09:40AM
Dec-19-23 04:01PM
(GlobeNewswire) +8.78%
-8.33%
Dec-05-23 04:01PM
Dec-04-23 09:35AM
09:35AM
Loading…
Nov-16-23 09:35AM
Nov-14-23 10:57AM
Nov-13-23 07:17AM
07:06AM
07:00AM
Nov-06-23 08:03AM
07:06AM
(Associated Press Finance)
07:00AM
Oct-03-23 07:00AM
Sep-20-23 07:00AM
Sep-18-23 07:00AM
Sep-14-23 07:03PM
(Motley Fool) +5.54%
-5.62%
Sep-08-23 05:06PM
Aug-10-23 06:07AM
Aug-08-23 08:40AM
Aug-07-23 08:15AM
07:10AM
07:00AM
Aug-01-23 07:53AM
Jul-06-23 08:19AM
Jun-26-23 10:15AM
Jun-13-23 06:30PM
07:01AM
Jun-02-23 07:00AM
May-18-23 01:50PM
May-10-23 06:04AM
May-08-23 11:55PM
(Thomson Reuters StreetEvents) -6.46%
08:15AM
07:08AM
07:00AM
May-05-23 06:49AM
May-02-23 07:01AM
Apr-27-23 04:35AM
Apr-24-23 02:37PM
Apr-04-23 07:40AM
Mar-27-23 07:00AM
Mar-10-23 11:34AM
(American City Business Journals)
Mar-06-23 03:59PM
02:32PM
01:03PM
11:50AM
07:00AM
Feb-23-23 08:35AM
07:00AM
Feb-22-23 06:01AM
Feb-09-23 04:01PM
Jan-06-23 07:01AM
Nov-29-22 07:00AM
Nov-26-22 01:39PM
(American City Business Journals)
Nov-22-22 04:01PM
Nov-16-22 12:10PM
Nov-10-22 04:01PM
Nov-08-22 08:25AM
07:00AM
Oct-26-22 06:44AM
Sep-27-22 07:00AM
Sep-15-22 06:46AM
Aug-30-22 07:00AM
Aug-25-22 07:00AM
Aug-05-22 07:59AM
Aug-03-22 08:25AM
07:00AM
Aug-01-22 07:00AM
Jul-15-22 12:00PM
Jul-08-22 09:40AM
Jul-01-22 09:36AM
(American City Business Journals)
Jun-27-22 07:00AM
Jun-22-22 09:40AM
Jun-20-22 08:20AM
Jun-13-22 09:55AM
Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through the Therapeutics and Contract Research segments. The Therapeutics segment focuses on identifying, developing, and commercializing different therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Wayne, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Leonard Braden Michael 10% Owner Jul 22 '24 Buy 1.33 17,716 23,557 13,602,691 Jul 22 04:03 PM Leonard Braden Michael 10% Owner Jul 19 '24 Buy 1.30 6,689 8,696 13,584,975 Jul 22 04:03 PM Leonard Braden Michael 10% Owner Jul 18 '24 Buy 1.30 130,317 169,555 13,578,286 Jul 22 04:03 PM Leonard Braden Michael 10% Owner Jul 05 '24 Buy 1.15 123,017 141,334 13,447,969 Jul 05 02:46 PM Leonard Braden Michael 10% Owner Jul 03 '24 Buy 1.16 143,288 166,071 13,324,952 Jul 05 02:46 PM Leonard Braden Michael 10% Owner Jul 02 '24 Buy 1.14 86,092 98,489 13,181,664 Jul 05 02:46 PM Leonard Braden Michael 10% Owner Jul 01 '24 Buy 1.14 107,434 122,185 13,095,572 Jul 01 01:39 PM Leonard Braden Michael 10% Owner Jun 28 '24 Buy 1.12 1,201,000 1,348,559 12,988,134 Jul 01 01:39 PM Leonard Braden Michael 10% Owner Jun 27 '24 Buy 1.15 235,000 271,331 11,787,134 Jul 01 01:39 PM Leonard Braden Michael 10% Owner Jun 18 '24 Buy 1.13 50,000 56,505 11,552,134 Jun 18 04:04 PM Leonard Braden Michael 10% Owner Jun 17 '24 Buy 1.13 150,000 169,500 11,502,134 Jun 18 04:04 PM Leonard Braden Michael 10% Owner Jun 14 '24 Buy 1.17 345,000 402,201 11,352,134 Jun 18 04:04 PM Leonard Braden Michael 10% Owner Jun 13 '24 Buy 1.15 528,621 607,757 11,007,134 Jun 13 06:04 PM Leonard Braden Michael 10% Owner Jun 12 '24 Buy 1.14 82,579 94,140 10,478,513 Jun 13 06:04 PM Leonard Braden Michael 10% Owner Jun 11 '24 Buy 1.08 1,000,000 1,080,000 10,395,934 Jun 13 06:04 PM Powell Andrew Kenneth William Director Mar 04 '24 Buy 1.25 6,000 7,500 28,863 Mar 05 04:58 PM Powell Andrew Kenneth William Director Mar 01 '24 Buy 1.23 8,500 10,455 22,863 Mar 05 04:58 PM Monahan Joseph Chief Scientific Officer Oct 23 '23 Sale 5.08 6,000 30,460 129,724 Oct 25 04:28 PM Balthaser Kevin Chief Financial Officer Sep 06 '23 Buy 7.90 9,490 74,971 15,461 Sep 07 04:16 PM Loerop James Chief Business Officer Aug 28 '23 Buy 6.80 14,705 99,959 21,688 Aug 28 04:39 PM Monahan Joseph Chief Scientific Officer Aug 21 '23 Sale 7.32 6,000 43,895 135,724 Aug 22 04:31 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite